The cluster is one-sided bullish but stale (Q3 2026 data filed with 45-day lag) and lacks insider corroboration. Monitor next 13F for whether Assenagon maintained or exited its new stake, and watch for any insider Form 4 filings that could confirm or contradict the institutional thesis.
EWTX drugs
EWTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $37.68entry
- T+1 · 13d ago −0.40%α −2.05% · $37.53
- T+5 · 7d ago +23.49%α +24.07% · $46.53
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three institutional investors increased their Edgewise Therapeutics positions in Q3 2026, led by a new $29.8M stake from Assenagon Asset Management. The cluster shows net buying of $30.7M, but the 45-day reporting lag and lack of insider buying (confluence score 2/100) weaken the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $30.7M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | NEW | +0% | $29.8M | $29.8M |
| Strs Ohio | ADD | +82% | $1.6M | $702.0K |
| Principal Financial Group | ADD | +51% | $335.0K | $113.0K |
Key Facts
- 3 institutional buyers added a net $30.7M in Q3 2026
- Assenagon Asset Management opened a new $29.8M position (735.2K shares)
- Strs Ohio added 82.0% ($702K increase) and Principal Financial Group added 51.0% ($113K increase)
- No institutional sellers in the cluster
- Insider buying confluence score is 2/100 (divergent), with zero open-market insider purchases
Financial Impact
3 institutions accumulated $30.7M in net new positions during Q3 2026, representing approximately 0.7% of the $4.2B market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- No insider buying to corroborate the institutional accumulation
- Only 3 institutions involved, with one (Assenagon) driving 97% of the net dollar change
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-EWTX-2026-Q3 |
Track record
14 reports on EWTX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 144 Neutral 1/10 Entry $43.68 settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $44.09 settles Feb 12
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $38.87 settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $38.87 settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Viewing Entry $37.68 settles Feb 1
- Aug 14, 202613w ago Insider Cluster Neutral 4/10 Entry $44.04 to $46.53 ▲ +5.65% +8.60% vs SPY
- Aug 14, 202613w ago Insider Cluster Neutral 3/10 Entry $44.04 to $46.53 ▲ +5.65% +8.60% vs SPY
- Aug 6, 202614w ago 8-K Mixed 7/10 Entry $44.42 to $38.90 ▼ −12.43% −10.76% vs SPY
- Jul 13, 202618w ago 8-K Bullish 7/10 Entry $41.27 to $40.02 ▼ −3.03% −7.02% vs SPY
- Jun 1, 202624w ago 8-K Bullish 8/10 Entry $40.26 to $44.21 ▲ +9.81% +8.58% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers